Sort
8,912 grants matching “sars cov 2”
Type 1-2 immune cross-regulation in the lung
$45,909Sofia Caryotakis · University Of California, San Francisco · F31 · FY2024 · HL
Covid-19 PPE for LMIC
$45,805Walter Tsong Lee · Duke University · R01 · FY2021 · DE
Development of a novel approach to characterize human chemosensory perception
$45,690Mackenzie E Hannum · Monell Chemical Senses Center · F32 · FY2021 · DC
Mechanisms of Pathogenesis in Staphylococcal Enterotoxin B-Induced Acute Respiratory Distress Syndrome
$45,662Chloe Weyer-Nichols · University Of South Carolina At Columbia · F31 · FY2025 · AI
Role of SARS-CoV-2 Spike Protein and Accessory ORFs in the immune pathogenesis of COVID-19
$45,608John H Kehrl · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Collaborative Research: RAPID: Wastewater Informed Epidemiological Monitoring of SARS-CoV-2
$45,503Joe Brown · Georgia Tech Research Corporation · · FY2020 · ENG
Intramural Diversity in Medical Research Initiatives
$45,436Kelvin Choi · National Institute On Minority Health And Health Disparities · ZIE · FY2024 · MD
One Health; Epidemiology of natural and deliberate contaminants (infectious and toxicities) in animals and animal food
$45,300Binu Velayudhan · University Of Georgia · U18 · FY2023 · FD
One Health; Epidemiology of natural and deliberate contaminants (infectious and toxicities) in animals and animal food
$45,300Binu Velayudhan · University Of Georgia · U18 · FY2024 · FD
One Health; Epidemiology of natural and deliberate contaminants (infectious and toxicities) in animals and animal food
$45,300Binu Velayudhan · University Of Georgia · U18 · FY2025 · FD
One Health; Epidemiology of natural and deliberate contaminants (infectious and toxicities) in animals and animal food
$45,300Binu Velayudhan · University Of Georgia · U18 · FY2022 · FD
Development of neutralizing nanobodies against SARS-CoV-2
$45,270Mitchell Ho · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
HDPTP
$45,259David Turcotte · University Of Massachusetts Lowell · U45 · FY2020 · ES
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
$45,214Jalene Velazquez · Washington State University · F31 · FY2024 · AI
Harnessing the power of extracellular matrix to treat COVID-19 ARDS
$45,173Stavros Garantziotis · National Institute Of Environmental Health Sciences · ZIA · FY2021 · ES
Effects of Age on Lipid Nanoparticle Delivery and mRNA Vaccination
$45,094Mariah Arral · Carnegie-Mellon University · F31 · FY2024 · AG
Atherogenic mechanisms of SVEP1, a Novel Human Coronary Artery Disease Locus
$45,040Jared Scott Elenbaas · Washington University · F30 · FY2023 · HL
Recover Losses Due to COVID-19 Pandemic
$45,000Margarita Vigodner · Yeshiva University · R15 · FY2022 · HD
2023 Lung Development, Injury and Repair Gordon Research Conference and Gordon Research Seminar
$45,000Xin Sun · Gordon Research Conferences · R13 · FY2023 · HL
Early and long term immunity following SARS-CoV-2 infection in humans
$44,999William Messer · Oregon Health & Science University · R01 · FY2022 · AI
Understanding spillover potential of European and African bat sarbecoviruses
$44,937Samantha Kathleen Zepeda · University Of Washington · F31 · FY2024 · AI
Understanding spatial and temporal dynamics of the SARS-CoV-2 receptor, ACE2
$44,930Hans Ackerman · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
SF Bay Area MACS/WIHS Combined Cohort Study
$44,725Phyllis C Tien · University Of California, San Francisco · U01 · FY2021 · HL
Next generation implicit solvation for atomistic modeling
$44,647Alexey Vlad Onufriev · Virginia Polytechnic Inst And St Univ · R01 · FY2024 · GM
Investigating MERS-CoV NS4b as a modulator of the host antiviral response in the nucleus
$44,044Stephen Goldstein · University Of Pennsylvania · F31 · FY2017 · AI